IFM Therapeutics launches new spinout aimed at Parkinson's, lupus and other diseases
February 11, 2019 at 07:30 AM EST
Boston biotech IFM Therapeutic, LLC is taking a second major step out from drug giant Bristol-Myers Squibb's wake this week, spinning out its second subsidiary focused on developing treatments for autoimmune and central nervous system diseases.